Find Research Outputs

Search in all content

Filters for Research Output

Search concepts
Selected Filters

Publication Year

  • 2020
  • 2019
  • 2018
  • 2017
  • 2016

Author

  • Julie Marie Vose
2020

Outcomes of patients with limited-stage aggressive large B-cell lymphoma with high-risk cytogenetics

Torka, P., Kothari, S. K., Sundaram, S., Li, S., Medeiros, L. J., Ayers, E. C., Landsburg, D. J., Bond, D. A., Maddocks, K. J., Giri, A., Hess, B., Pham, L. Q., Advani, R., Liu, Y., Barta, S. K., Vose, J. M., Churnetski, M. C., Cohen, J. B., Burkart, M., Karmali, R. & 12 others, Zurko, J., Mehta, A., Olszewski, A. J., Lee, S., Hill, B. T., Burns, T. F., Lansigan, F., Rabinovich, E., Peace, D., Groman, A., Attwood, K. & Hernandez-Ilizaliturri, F. J., Jan 28 2020, In : Blood Advances. 4, 2, p. 253-262 10 p.

Research output: Contribution to journalArticle

Open Access

Targeting translation initiation by synthetic rocaglates for treating MYC-driven lymphomas

Zhang, X., Bi, C., Lu, T., Zhang, W., Yue, T., Wang, C., Tian, T., Zhang, X., Huang, Y., Lunning, M., Hao, X., Brown, L. E., Devine, W. G., Vose, J., Porco, J. A. & Fu, K., Jan 1 2020, In : Leukemia. 34, 1, p. 138-150 13 p.

Research output: Contribution to journalArticle

Three-year outcomes with brentuximab vedotin plus bendamustine as first salvage therapy in relapsed or refractory Hodgkin lymphoma

LaCasce, A. S., Bociek, R. G., Sawas, A., Caimi, P., Agura, E., Matous, J., Ansell, S. M., Crosswell, H. E., Islas-Ohlmayer, M., Behler, C., Cheung, E., Forero-Torres, A., Vose, J., O’Connor, O. A., Josephson, N., Wang, Y. & Advani, R., Jan 1 2020, (Accepted/In press) In : British Journal of Haematology.

Research output: Contribution to journalLetter

Open Access
1 Scopus citations
2019

ALK-positive anaplastic large-cell lymphoma in adults: An individual patient data pooled analysis of 263 patients

Sibon, D., Nguyen, D. P., Schmitz, N., Suzuki, R., Feldman, A. L., Gressin, R., Lamant, L., Weisenburger, D. D., Rosenwald, A., Nakamura, S., Ziepert, M., Maurer, M. J., Bast, M., Armitage, J. O., Vose, J. M., Tilly, H., Jais, J. P. & Savage, K. J., Jan 1 2019, In : Haematologica. 104, 12, p. E562-E565

Research output: Contribution to journalLetter

Open Access
4 Scopus citations

A novel approach to eliminate therapy-resistant mantle cell lymphoma: synergistic effects of Vorinostat with Palbociclib

Chaturvedi, N. K., Hatch, N. D., Sutton, G. L., Kling, M., Vose, J. M. & Joshi, S. S., Apr 16 2019, In : Leukemia and Lymphoma. 60, 5, p. 1214-1223 10 p.

Research output: Contribution to journalArticle

2 Scopus citations

Assessing an ASCO decision aid for improving the accuracy and attribution of serious adverse event reporting from investigators to sponsors

Mileham, K. F., Schenkel, C., Chuk, M. K., Buchmeier, A., Perez, R. P., Hurley, P., Levit, L. A., Garrett-Mayer, E., Davis, C., Bruinooge, S. S. & Vose, J., Jan 1 2019, In : Journal of oncology practice. 15, 12, p. e1050-e1065

Research output: Contribution to journalArticle

Chemoimmunotherapy for localised low-risk diffuse large B-cell lymphoma

Vose, J. M., Dec 21 2019, In : The Lancet. 394, 10216, p. 2208-2209 2 p.

Research output: Contribution to journalComment/debate

Clinical impact of Internet-based tools to guide therapeutic decisions for mantle cell lymphoma

Gopalsamy, S. N., Rosenthal, K. M., Ayers, A. A., Goy, A., Leonard, J. P., Vose, J. M., Obholz, K. L., Armitage, J. O. & Flowers, C. R., Jul 29 2019, In : Leukemia and Lymphoma. 60, 9, p. 2255-2263 9 p.

Research output: Contribution to journalArticle

Effects of center type and socioeconomic factors on early mortality and overall survival of diffuse large B-cell lymphoma

Dhakal, P., Chen, B., Giri, S., Vose, J. M., Armitage, J. O. & Bhatt, V. R., Jun 2019, In : Future Oncology. 15, 18, p. 2113-2124 12 p.

Research output: Contribution to journalArticle

Genetic drivers of oncogenic pathways in molecular subgroups of peripheral T-cell lymphoma

Heavican, T. B., Bouska, A., Yu, J., Lone, W., Amador, C., Gong, Q., Zhang, W., Li, Y., Dave, B. J., Nairismägi, M. L., Greiner, T. C., Vose, J., Weisenburger, D. D., Lachel, C., Wang, C., Fu, K., Stevens, J. M., Lim, S. T., Ong, C. K., Gascoyne, R. D. & 27 others, Missiaglia, E., Lemonnier, F., Haioun, C., Hartmann, S., Pedersen, M. B., Laginestra, M. A., Wilcox, R. A., Teh, B. T., Yoshida, N., Ohshima, K., Seto, M., Rosenwald, A., Ott, G., Campo, E., Rimsza, L. M., Jaffe, E. S., Braziel, R. M., d’Amore, F., Inghirami, G., Bertoni, F., de Leval, L., Gaulard, P., Staudt, L. M., McKeithan, T. W., Pileri, S., Chan, W. C. & Iqbal, J., Apr 11 2019, In : Blood. 133, 15, p. 1664-1676 13 p.

Research output: Contribution to journalArticle

24 Scopus citations

Hope after salvage therapy fails: Novel agents for relapsed/refractory hodgkin lymphoma

Kallam, A. & Vose, J. M., Jan 1 2019, In : ONCOLOGY (United States). 33, 5, p. 192-198 7 p.

Research output: Contribution to journalReview article

Maintenance Therapies for Hodgkin and Non-Hodgkin Lymphomas after Autologous Transplantation: A Consensus Project of ASBMT, CIBMTR, and the Lymphoma Working Party of EBMT

Kanate, A. S., Kumar, A., Dreger, P., Dreyling, M., Le Gouill, S., Corradini, P., Bredeson, C., Fenske, T. S., Smith, S. M., Sureda, A., Moskowitz, A., Friedberg, J. W., Inwards, D. J., Herrera, A. F., Kharfan-Dabaja, M. A., Reddy, N., Montoto, S., Robinson, S. P., Abutalib, S. A., Gisselbrecht, C. & 7 others, Vose, J., Gopal, A., Shadman, M., Perales, M. A., Carpenter, P., Savani, B. N. & Hamadani, M., May 2019, In : JAMA Oncology. 5, 5, p. 715-722 8 p.

Research output: Contribution to journalArticle

9 Scopus citations

Phase I/II study of dasatinib and exploratory genomic analysis in relapsed or refractory non-Hodgkin lymphoma

Umakanthan, J. M., Iqbal, J., Batlevi, C. L., Bouska, A., Smith, L. M., Shostrom, V., Nutsch, H., William, B. M., Gregory Bociek, R., Lunning, M., Bierman, P., Younes, A., Armitage, J. O. & Vose, J. M., Mar 2019, In : British Journal of Haematology. 184, 5, p. 744-752 9 p.

Research output: Contribution to journalArticle

3 Scopus citations

Recent Advances in CAR-T Cell Therapy for Non-Hodgkin Lymphoma

Kallam, A. & Vose, J. M., Dec 2019, In : Clinical Lymphoma, Myeloma and Leukemia. 19, 12, p. 751-757 7 p.

Research output: Contribution to journalReview article

1 Scopus citations

Reproducing the molecular subclassification of peripheral T-cell lymphoma–NOS by immunohistochemistry

on behalf of the Lymphoma/Leukemia Molecular Profiling Project, Dec 12 2019, In : Blood. 134, 24, p. 2159-2170 12 p.

Research output: Contribution to journalArticle

6 Scopus citations

Survival outcomes of younger patients with mantle cell lymphoma treated in the rituximab era

Gerson, J. N., Handorf, E., Villa, D., Gerrie, A. S., Chapani, P., Li, S., Jeffrey Medeiros, L., Wang, M. I., Cohen, J. B., Calzada, O., Churnetski, M. C., Hill, B. T., Sawalha, Y., Hernandez-Ilizaliturri, F. J., Kothari, S., Vose, J. M., Bast, M. A., Fenske, T. S., Gari, S. N. R., Maddocks, K. J. & 30 others, Bond, D., Bachanova, V., Kolla, B., Chavez, J., Shah, B., Lansigan, F., Burns, T. F., Donovan, A. M., Wagner-Johnston, N., Messmer, M., Mehta, A., Anderson, J. K., Reddy, N., Kovach, A. E., Landsburg, D. J., Glenn, M., Inwards, D. J., Karmali, R., Kaplan, J. B., Caimi, P. F., Rajguru, S., Evens, A., Klein, A., Umyarova, E., Pulluri, B., Amengual, J. E., Lue, J. K., Diefenbach, C., Fisher, R. I. & Barta, S. K., Jan 1 2019, In : Journal of Clinical Oncology. 37, 6, p. 471-480 10 p.

Research output: Contribution to journalArticle

9 Scopus citations

Targetable genetic alterations of TCF4 (E2-2) drive immunoglobulin expression in diffuse large B cell lymphoma

Jain, N., Hartert, K., Tadros, S., Fiskus, W., Havranek, O., Ma, M. C. J., Bouska, A., Heavican, T., Kumar, D., Deng, Q., Moore, D., Pak, C., Liu, C. L., Gentles, A. J., Hartmann, E., Kridel, R., Smedby, K. E., Juliusson, G., Rosenquist, R., Gascoyne, R. D. & 13 others, Rosenwald, A., Giancotti, F., Neelapu, S. S., Westin, J., Vose, J. M., Lunning, M. A., Greiner, T., Rodig, S., Iqbal, J., Alizadeh, A. A., Davis, R. E., Bhalla, K. & Green, M. R., Jan 1 2019, In : Science translational medicine. 11, 497, eaav5599.

Research output: Contribution to journalArticle

5 Scopus citations

Tolerability and activity of ublituximab, umbralisib, and ibrutinib in patients with chronic lymphocytic leukaemia and non-Hodgkin lymphoma: a phase 1 dose escalation and expansion trial

Nastoupil, L. J., Lunning, M. A., Vose, J. M., Schreeder, M. T., Siddiqi, T., Flowers, C. R., Cohen, J. B., Burger, J. A., Wierda, W. G., O'Brien, S., Sportelli, P., Miskin, H. P., Purdom, M. A., Weiss, M. S. & Fowler, N. H., Feb 2019, In : The Lancet Haematology. 6, 2, p. e100-e109

Research output: Contribution to journalArticle

20 Scopus citations

Ublituximab and umbralisib in relapsed/refractory B-cell non-Hodgkin lymphoma and chronic lymphocytic leukemia

Lunning, M., Vose, J., Nastoupil, L., Fowler, N., Burger, J. A., Wierda, W. G., Schreeder, M. T., Siddiqi, T., Flowers, C. R., Cohen, J. B., Sportelli, P., Miskin, H. P., Weiss, M. S. & O'Brien, S., Nov 21 2019, In : Blood. 134, 21, p. 1811-1820 10 p.

Research output: Contribution to journalArticle

7 Scopus citations
2018

American society of clinical oncology's global oncology leadership task force: Findings and actions

Hortobagyi, G. N., Pyle, D., Cazap, E. L., El Saghir, N. S., Shulman, L. N., Lyman, G. H., Schnipper, L. E., Adebamowo, C. A., Gandara, D. R., Vose, J., Wong, S. L. & Yu, P., Mar 1 2018, In : Journal of Global Oncology. 2018, 4

Research output: Contribution to journalArticle

5 Scopus citations

Autologous transplantation versus allogeneic transplantation in patients with follicular lymphoma experiencing early treatment failure

Smith, S. M., Godfrey, J., Ahn, K. W., DiGilio, A., Ahmed, S., Agrawal, V., Bachanova, V., Bacher, U., Bashey, A., Bolaños-Meade, J., Cairo, M., Chen, A., Chhabra, S., Copelan, E., Dahi, P. B., Aljurf, M., Farooq, U., Ganguly, S., Hertzberg, M., Holmberg, L. & 20 others, Inwards, D., Kanate, A. S., Karmali, R., Kenkre, V. P., Kharfan-Dabaja, M. A., Klein, A., Lazarus, H. M., Mei, M., Mussetti, A., Nishihori, T., Ramakrishnan Geethakumari, P., Saad, A., Savani, B. N., Schouten, H. C., Shah, N., Urbano-Ispizua, A., Vij, R., Vose, J., Sureda, A. & Hamadani, M., Jun 15 2018, In : Cancer. 124, 12, p. 2541-2551 11 p.

Research output: Contribution to journalArticle

13 Scopus citations

Brentuximab vedotin plus bendamustine: a highly active first salvage regimen for relapsed or refractory Hodgkin lymphoma

LaCasce, A. S., Gregory Bociek, R., Sawas, A., Caimi, P., Agura, E., Matous, J., Ansell, S. M., Crosswell, H. E., Islas-Ohlmayer, M., Behler, C., Cheung, E., Forero-Torres, A., Vose, J., O’Connor, O. A., Josephson, N., Wang, Y. & Advani, R., Jul 5 2018, In : Blood. 132, 1, p. 40-48 9 p.

Research output: Contribution to journalArticle

47 Scopus citations

Diagnosis and treatment of non-hodgkin’s lymphoma of adults

Crockett, D. G., Armitage, J. O. & Vose, J. M., Jan 1 2018, Neoplastic Diseases of the Blood. Springer International Publishing, p. 951-973 23 p.

Research output: Chapter in Book/Report/Conference proceedingChapter

Follicular large cleaved cell (centrocytic) lymphoma: an unrecognized variant of follicular lymphoma

El Behery, R., Laurini, J. A., Weisenburger, D. D., Smith, L. M., Dave, B. J., Yuan, J., Fu, K., Chan, W. C., Nathwani, B. N., Bierman, P. J., Bociek, R. G., Vose, J. M., Armitage, J. O., Greiner, T. C. & Aoun, P., Feb 2018, In : Human Pathology. 72, p. 180-190 11 p.

Research output: Contribution to journalArticle

1 Scopus citations

Interim results of brentuximab vedotin in combination with nivolumab in patients with relapsed or refractory Hodgkin lymphoma

Herrera, A. F., Moskowitz, A. J., Bartlett, N. L., Vose, J. M., Ramchandren, R., Feldman, T. A., LaCasce, A. S., Ansell, S. M., Moskowitz, C. H., Fenton, K., Ogden, C. A., Taft, D., Zhang, Q., Kato, K., Campbell, M. & Advani, R. H., Mar 15 2018, In : Blood. 131, 11, p. 1183-1194 12 p.

Research output: Contribution to journalArticle

97 Scopus citations

Mantle Cell Lymphoma

Bhatt, V. R., Valdes, R. F. & Vose, J. M., Jan 1 2018, Hematology: Basic Principles and Practice. Elsevier Inc., p. 1298-1308.e2

Research output: Chapter in Book/Report/Conference proceedingChapter

Peripheral T-cell lymphoma: Novel backbone

Vose, J. M., Jan 25 2018, In : Blood. 131, 4, p. 375-376 2 p.

Research output: Contribution to journalReview article

Peripheral T cell lymphoma, not otherwise specified (PTCL-NOS). A new prognostic model developed by the International T cell Project Network

the T cell Project Network, Jun 2018, In : British Journal of Haematology. 181, 6, p. 760-769 10 p.

Research output: Contribution to journalArticle

13 Scopus citations

PLK1 stabilizes a MYC-dependent kinase network in aggressive B cell lymphomas

Ren, Y., Bi, C., Zhao, X., Lwin, T., Wang, C., Yuan, J., Silva, A. S., Shah, B. D., Fang, B., Li, T., Koomen, J. M., Jiang, H., Chavez, J. C., Pham, L. V., Sudalagunta, P. R., Wan, L., Wang, X., Dalton, W. S., Moscinski, L. C., Shain, K. H. & 5 others, Vose, J., Cleveland, J. L., Sotomayor, E. M., Fu, K. & Tao, J., Dec 3 2018, In : Journal of Clinical Investigation. 128, 12, p. 5531-5548 18 p.

Research output: Contribution to journalArticle

16 Scopus citations

Rac1 is a novel therapeutic target in mantle cell lymphoma

Tian, T., Bi, C., Hein, A. L., Zhang, X., Wang, C., Shen, S., Yuan, J., Greiner, T. C., Enke, C., Vose, J., Yan, Y. & Fu, K., Feb 1 2018, In : Blood Cancer Journal. 8, 2, 17.

Research output: Contribution to journalArticle

8 Scopus citations

R-CHOP versus dose-adjusted R-EPOCH in frontline management of primary mediastinal B-cell lymphoma: a multi-centre analysis

Shah, N. N., Szabo, A., Huntington, S. F., Epperla, N., Reddy, N., Ganguly, S., Vose, J., Obiozor, C., Faruqi, F., Kovach, A. E., Costa, L. J., Xaiver, A. C., Okal, R., Kanate, A. S., Ghosh, N., Kharfan-Dabaja, M. A., Strelec, L., Hamadani, M., Fenske, T. S., Calzada, O. & 3 others, Cohen, J. B., Chavez, J. & Svoboda, J., Feb 1 2018, In : British Journal of Haematology. 180, 4, p. 534-544 11 p.

Research output: Contribution to journalArticle

22 Scopus citations

Streamlining adverse events reporting in oncology: An American society of clinical oncology research statement

Levit, L. A., Perez, R. P., Smith, D. C., Schilsky, R. L., Hayes, D. F. & Vose, J. M., Feb 20 2018, In : Journal of Clinical Oncology. 36, 6, p. 617-623 7 p.

Research output: Contribution to journalArticle

5 Scopus citations
2017

Adult high-grade B-cell lymphoma with Burkitt lymphoma signature: Genomic features and potential therapeutic targets

Bouska, A., Bi, C., Lone, W., Zhang, W., Kedwaii, A., Heavican, T., Lachel, C. M., Yu, J., Ferro, R., Eldorghamy, N., Greiner, T. C., Vose, J., Weisenburger, D. D., Gascoyne, R. D., Rosenwald, A., Ott, G., Campo, E., Rimsza, L. M., Jaffe, E. S., Braziel, R. M. & 12 others, Siebert, R., Miles, R. R., Dave, S., Reddy, A., Delabie, J., Staudt, L. M., Song, J. Y., McKeithan, T. W., Fu, K., Green, M., Chan, W. C. & Iqbal, J., Oct 19 2017, In : Blood. 130, 16, p. 1819-1831 13 p.

Research output: Contribution to journalArticle

24 Scopus citations

Angioimmunoblastic T-cell lymphoma: The many-faced lymphoma

Lunning, M. A. & Vose, J. M., Mar 2 2017, In : Blood. 129, 9, p. 1095-1102 8 p.

Research output: Contribution to journalReview article

31 Scopus citations

Challenges in Opening and Enrolling Patients in Clinical Trials

Vose, J. M., Chuk, M. K. & Giles, F., Jan 1 2017, In : American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting. 37, p. 139-143 5 p.

Research output: Contribution to journalReview article

Clinicopathologic consensus study of gray zone lymphoma with features intermediate between DLBCL and classical HL

Pilichowska, M., Pittaluga, S., Ferry, J. A., Hemminger, J., Chang, H., Kanakry, J. A., Sehn, L. H., Feldman, T., Abramson, J. S., Kritharis, A., Hernandez-Ilizaliturri, F. J., Lossos, I. S., Press, O. W., Fenske, T. S., Friedberg, J. W., Vose, J. M., Blum, K. A., Jagadeesh, D., Woda, B., Gupta, G. K. & 3 others, Gascoyne, R. D., Jaffe, E. S. & Evens, A. M., Dec 12 2017, In : Blood Advances. 1, 26, p. 2600-2609 10 p.

Research output: Contribution to journalArticle

Open Access
20 Scopus citations

Combined copy number and mutation analysis identifies oncogenic pathways associated with transformation of follicular lymphoma

Bouska, A., Zhang, W., Gong, Q., Iqbal, J., Scuto, A., Vose, J., Ludvigsen, M., Fu, K., Weisenburger, D. D., Greiner, T. C., Gascoyne, R. D., Rosenwald, A., Ott, G., Campo, E., Rimsza, L. M., Delabie, J., Jaffe, E. S., Braziel, R. M., Connors, J. M., Wu, C. I. & 4 others, Staudt, L. M., D'Amore, F., McKeithan, T. W. & Chan, W. C., Jan 1 2017, In : Leukemia. 31, 1, p. 83-91 9 p.

Research output: Contribution to journalArticle

37 Scopus citations

Crebbp loss cooperates with Bcl2 overexpression to promote lymphoma in mice

García-Ramírez, I., Tadros, S., González-Herrero, I., Martín-Lorenzo, A., Rodríguez-Hernández, G., Moore, D., Ruiz-Roca, L., Blanco, O., Alonso-López, D., De Las Rivas, J., Hartert, K., Duval, R., Klinkebiel, D., Bast, M., Vose, J., Lunning, M., Fu, K., Greiner, T., Rodrigues-Lima, F., Jiménez, R. & 7 others, Criado, F. J. G., Cenador, M. B. G., Brindle, P., Vicente-Dueñas, C., Alizadeh, A., Sánchez-García, I. & Green, M. R., May 11 2017, In : Blood. 129, 19, p. 2645-2656 12 p.

Research output: Contribution to journalArticle

27 Scopus citations

Delivery of personalized medicine with precision

Hayes, D. F. & Vose, J. M., Jan 1 2017, In : JCO Precision Oncology. 2017, 1, p. 1-3 3 p.

Research output: Contribution to journalEditorial

Inhibition of 4EBP phosphorylation mediates the cytotoxic effect of mechanistic target of rapamycin kinase inhibitors in aggressive B-cell lymphomas

Bi, C., Zhang, X., Lu, T., Zhang, X., Wang, X., Meng, B., Zhang, H., Wang, P., Vose, J. M., Chan, W. C., McKeithan, T. W. & Fu, K., Mar 31 2017, In : Haematologica. 102, 4, p. 755-764 10 p.

Research output: Contribution to journalArticle

12 Scopus citations

Learning from our patients

Vose, J. M. & Hayes, D., Jan 1 2017, In : JCO Clinical Cancer Informatics. 2017, 1, p. 1-3 3 p.

Research output: Contribution to journalArticle

Mantle cell lymphoma: 2017 update on diagnosis, risk-stratification, and clinical management

Vose, J. M., Aug 2017, In : American Journal of Hematology. 92, 8, p. 806-813 8 p.

Research output: Contribution to journalArticle

62 Scopus citations

NCCN guidelines® insights chronic Lymphocytic Leukemia/Small Lymphocytic Leukemia, Version 1.2017: Featured updates to the NCCN guidelines

Wierda, W. G., Zelenetz, A. D., Gordon, L. I., Abramson, J. S., Advani, R. H., Andreadis, C. B., Bartlett, N., Byrd, J. C., Caimi, P., Fayad, L. E., Fisher, R. I., Glenn, M. J., Habermann, T. M., Harris, N. L., Hernandez-Ilizaliturri, F., Hoppe, R. T., Horwitz, S. M., Kaminski, M. S., Kelsey, C. R., Kim, Y. H. & 18 others, Krivacic, S., LaCasce, A. S., Martin, M. G., Nademanee, A., Porcu, P., Press, O., Rabinovitch, R., Reddy, N., Reid, E., Roberts, K., Saad, A. A., Snyder, E. D., Sokol, L., Swinnen, L. J., Vose, J. M., Yahalom, J., Dwyer, M. A. & Sundar, H., Mar 1 2017, In : JNCCN Journal of the National Comprehensive Cancer Network. 15, 3, p. 293-311 19 p.

Research output: Contribution to journalReview article

Open Access
32 Scopus citations

Outcomes of patients with double-hit lymphoma who achieve first complete remission

Landsburg, D. J., Mato, A. R., Gerson, J. N., Barta, S. K., Falkiewicz, M. K., Howlett, C., Feldman, T., Maly, J., Blum, K. A., Hill, B. T., Li, S., Medeiros, L. J., Torka, P., Hernandez-Ilizaliturri, F., Lue, J. K., Amengual, J. E., Reddy, N. M., Singavi, A., Fenske, T. S., Chavez, J. C. & 15 others, Kaplan, J. B., Behdad, A., Petrich, A. M., Peace, D. J., Nathan, S., Bast, M. A., Vose, J. M., Olszewski, A. J., Costa, C., Lansigan, F., Calzada, O., Cohen, J. B., Rivera, X., Persky, D. O. & Cassaday, R. D., Jul 10 2017, In : Journal of Clinical Oncology. 35, 20, p. 2260-2267 8 p.

Research output: Contribution to journalArticle

51 Scopus citations

Pitfalls and major issues in the histologic diagnosis of peripheral T-cell lymphomas: results of the central review of 573 cases from the T-Cell Project, an international, cooperative study

Bellei, M., Sabattini, E., Pesce, E. A., Ko, Y. H., Kim, W. S., Cabrera, M. E., Martinez, V., Dlouhy, I., Paes, R. P., Barrese, T., Vassallo, J., Tarantino, V., Vose, J., Weisenburger, D., Rüdiger, T., Federico, M. & Pileri, S., Dec 2017, In : Hematological Oncology. 35, 4, p. 630-636 7 p.

Research output: Contribution to journalArticle

9 Scopus citations
9 Scopus citations
3 Scopus citations

The landscape of new drugs in lymphoma

Younes, A., Ansell, S., Fowler, N., Wilson, W., De Vos, S., Seymour, J., Advani, R., Forero, A., Morschhauser, F., Kersten, M. J., Tobinai, K., Zinzani, P. L., Zucca, E., Abramson, J. & Vose, J., Jun 1 2017, In : Nature Reviews Clinical Oncology. 14, 6, p. 335-346 12 p.

Research output: Contribution to journalReview article

34 Scopus citations
2016

2016 ASCO presidential address: "collective Wisdom: The future of patient-centered care and research"

Vose, J. M., Sep 1 2016, In : Journal of Clinical Oncology. 34, 25, p. 2945-2949 5 p.

Research output: Contribution to journalReview article

Addressing administrative and regulatory burden in cancer clinical trials: Summary of a stakeholder survey and workshop hosted by the American society of clinical oncology and the association of American Cancer Institutes

Vose, J. M., Levit, L. A., Hurley, P., Lee, C., Thompson, M. A., Stewart, T., Hofacker, J., Bruinooge, S. S. & Hayes, D. F., Nov 1 2016, In : Journal of Clinical Oncology. 34, 31, p. 3796-3802 7 p.

Research output: Contribution to journalReview article

14 Scopus citations